VHB937

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VHB937, covering 2026-03-23 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

See pricing